315 research outputs found
On-site correlation in valence and core states of ferromagnetic nickel
We present a method which allows to include narrow-band correlation effects
into the description of both valence and core states and we apply it to the
prototypical case of nickel. The results of an ab-initio band calculation are
used as input mean-field eigenstates for the calculation of self-energy
corrections and spectral functions according to a three-body scattering
solution of a multi-orbital Hubbard hamiltonian. The calculated quasi-particle
spectra show a remarkable agreement with photoemission data in terms of band
width, exchange splitting, satellite energy position of valence states, spin
polarization of both the main line and the satellite of the 3p core level.Comment: 14 pages, 10 PostScript figures, RevTeX, submitted to PR
Unified N=2 Maxwell-Einstein and Yang-Mills-Einstein Supergravity Theories in Four Dimensions
We study unified N=2 Maxwell-Einstein supergravity theories (MESGTs) and
unified Yang-Mills Einstein supergravity theories (YMESGTs) in four dimensions.
As their defining property, these theories admit the action of a global or
local symmetry group that is (i) simple, and (ii) acts irreducibly on all the
vector fields of the theory, including the ``graviphoton''. Restricting
ourselves to the theories that originate from five dimensions via dimensional
reduction, we find that the generic Jordan family of MESGTs with the scalar
manifolds [SU(1,1)/U(1)] X [SO(2,n)/SO(2)X SO(n)] are all unified in four
dimensions with the unifying global symmetry group SO(2,n). Of these theories
only one can be gauged so as to obtain a unified YMESGT with the gauge group
SO(2,1). Three of the four magical supergravity theories defined by simple
Euclidean Jordan algebras of degree 3 are unified MESGTs in four dimensions.
Two of these can furthermore be gauged so as to obtain 4D unified YMESGTs with
gauge groups SO(3,2) and SO(6,2), respectively. The generic non-Jordan family
and the theories whose scalar manifolds are homogeneous but not symmetric do
not lead to unified MESGTs in four dimensions. The three infinite families of
unified five-dimensional MESGTs defined by simple Lorentzian Jordan algebras,
whose scalar manifolds are non-homogeneous, do not lead directly to unified
MESGTs in four dimensions under dimensional reduction. However, since their
manifolds are non-homogeneous we are not able to completely rule out the
existence of symplectic sections in which these theories become unified in four
dimensions.Comment: 47 pages; latex fil
Bankruptcy Treatment of Intellectual Property Assets: An Economic Analysis
With the rise of intellectual property in the modern economy, bankruptcy treatment of intellectual property assets has taken on ever greater importance. The law in this area must balance different approaches to asset management. Viewing the world from an ex ante perspective, intellectual property laws seek to foster investment in research and development. Freedom of contract plays a central role in maximizing the potential value of intellectual property by encouraging a robust licensing market to exploit the value of intellectual creativity. By contrast, the bankruptcy system generally views asset management from an ex post standpoint, focusing narrowly on how to maximize the value of a failing or failed enterprise. Thus, bankruptcy law affords trustees and debtors substantial leeway to rescind contracts and reorder the affairs of the failed entity. This article examines the rather complex rules governing the treatment of intellectual property assets in bankruptcy and suggests various reforms that could better promote economic efficiency
Prognosis of sciatica and back-related leg pain in primary care: the ATLAS cohort
BACKGROUND CONTEXT: Evidence is lacking on the prognosis and prognostic factors of back-related leg pain and sciatica in patients seeing their primary care physicians. This evidence could guide timely appropriate treatment and referral decisions.
PURPOSE: The present study aims to describe the prognosis and prognostic factors in primary care patients with low back-related leg pain and sciatica.
STUDY DESIGN: This is a prospective cohort study.
PATIENT SAMPLE: The present study included adults visiting their family doctor with back-related leg pain in the United Kingdom.
OUTCOME MEASURES: Information about pain, function, psychological, and clinical variables, was collected. Good outcome was defined as 30% or more reduction in disability (Roland-Morris Disability Questionnaire).
METHODS: Participants completed the questionnaires, underwent clinical assessments, received a magnetic resonance imaging scan, and were followed-up 12 months later. Mixed-effects logistic regression evaluated the prognostic value of six a priori defined variable sets (leg pain duration, pain intensity, neuropathic pain, psychological factors, clinical examination, and imaging variables). A combined model, including variables from all models, examined independent effects. The National Institute for Health Research funded the study. There are no conflicts of interest.
RESULTS: A total of 609 patients were included. At 12 months, 55% of patients improved in both the total sample and the sciatica group. For the whole cohort, longer leg pain duration (odds ratio [OR] 0.41; confidence interval [CI] 0.19-0.90), higher identity score (OR 0.70; CI 0.53-0.93), and patient's belief that the problem will last a long time (OR 0.27; CI 0.13-0.57) were the strongest independent prognostic factors negatively associated with improvement. These last two factors were similarly negatively associated with improvement in the sciatica subgroup.
CONCLUSIONS: The present study provides new evidence on the prognosis and prognostic factors of back-related leg pain and sciatica in primary care. Just over half of patients improved at 12 months. Patient's belief of recovery timescale and number of other symptoms attributed to the pain are independent prognostic factors. These factors can be used to inform and direct decisions about timing and intensity of available therapeutic options
- …